Healthcare Innovation
-
ALS Patient Improves, Still Works as Physician After RNA Therapy
BETHESDA, September 19 — A man with a rare, inherited form of amyotrophic lateral sclerosis has become the first person to receive…
-
How Oncotype DX Works: The 21-Gene Recurrence Score Explained
MUNICH, July 17 — A gene expression profiling test that has become a standard tool in breast cancer treatment decisions works by…
-
Clinical Risk Score Helps Guide Chemotherapy Choices for Younger Women After Oncotype DX Test
NEW YORK, July 17 — For patients facing a breast cancer diagnosis, the decision about chemotherapy has long been one of medicine’s…
-
NIH says All of Us is now the world’s largest integrated health database
NEW YORK, July 1 — 747,000 participants. That is the headline number for the National Institutes of Health’s All of Us research…
-
Health Systems Invest in Cadence’s Remote Patient Monitoring Platform
Health systems are putting money into remote patient monitoring. That is the real story behind Cadence’s new $100 million funding round. Spark…
-
Roche Brings 7-Minute Lung Cancer Shot to India at About ₹3.7 Lakh a Dose
MUMBAI — For lung cancer patients in India, a treatment that once meant sitting for an hour or more with an IV…
-
7-Minute Injection To Treat Lung Cancer Comes To India
MUMBAI, June 9, 2026 — infopulsetoday.com — Roche Pharma India has announced the launch of Tecentriq® (atezolizumab) SC in India, the country’s…
-
Bahrain Approved Casgevy Gene Therapy in 2023, Then Treated Its First Sickle Cell Patient
On December 2, 2023, regulators in the Kingdom of Bahrain granted approval for a gene therapy targeting two inherited blood conditions. The…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992